Clinical Trial Update: Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing management of platelet transfusion therapy in patients with blood cancers or treatment-induced thrombocytopenia; trial terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• B-cell Non-hodgkin Lymphoma
• Biphenotypic Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia Bcr-abl1 Positive
• Hematologic and Lymphocytic Disorder
• Hematopoietic Cell Transplantation Recipient
• Myelodysplastic Syndrome
• Myelofibrosis
• T-cell Non-hodgkin Lymphoma
• Thrombocytopenia
• Venous Thromboembolism

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2019-10-21